Linde India Ltd
Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.[1]
- Market Cap ₹ 54,797 Cr.
- Current Price ₹ 6,426
- High / Low ₹ 8,781 / 5,202
- Stock P/E 122
- Book Value ₹ 448
- Dividend Yield 0.07 %
- ROCE 16.9 %
- ROE 12.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 21.7%
Cons
- Stock is trading at 14.4 times its book value
- The company has delivered a poor sales growth of 7.12% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Industrial Gases
Part of BSE 500 BSE 200 Nifty 500 BSE MidCap Nifty MNC
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 15m | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
1,825 | 2,033 | 2,192 | 1,762 | 1,471 | 2,112 | 3,136 | 2,769 | 2,485 | 2,403 | |
1,539 | 1,705 | 1,866 | 1,347 | 1,096 | 1,564 | 2,371 | 2,066 | 1,720 | 1,625 | |
Operating Profit | 287 | 328 | 326 | 415 | 375 | 548 | 765 | 702 | 765 | 778 |
OPM % | 16% | 16% | 15% | 24% | 25% | 26% | 24% | 25% | 31% | 32% |
40 | 8 | 15 | 862 | 36 | 335 | 113 | 85 | 75 | 60 | |
Interest | 116 | 116 | 103 | 86 | 6 | 3 | 6 | 7 | 13 | 14 |
Depreciation | 195 | 206 | 199 | 177 | 176 | 181 | 253 | 201 | 214 | 218 |
Profit before tax | 16 | 13 | 39 | 1,013 | 229 | 698 | 618 | 579 | 614 | 606 |
Tax % | -20% | -21% | 35% | 28% | 34% | 27% | 13% | 25% | 26% | |
19 | 16 | 26 | 727 | 151 | 507 | 538 | 434 | 455 | 448 | |
EPS in Rs | 2.23 | 1.90 | 3.01 | 85.27 | 17.72 | 59.47 | 63.09 | 50.90 | 53.33 | 52.57 |
Dividend Payout % | 34% | 53% | 50% | 12% | 17% | 23% | 19% | 24% | 22% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | 6% |
TTM: | -11% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 30% |
3 Years: | 14% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 36% |
5 Years: | 57% |
3 Years: | 24% |
1 Year: | -13% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 14% |
Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 |
Reserves | 1,356 | 1,365 | 1,377 | 2,087 | 2,149 | 2,630 | 3,055 | 3,383 | 3,735 |
1,445 | 1,282 | 1,199 | 108 | 7 | 24 | 22 | 21 | 42 | |
722 | 680 | 759 | 970 | 1,045 | 1,277 | 1,238 | 1,316 | 1,280 | |
Total Liabilities | 3,608 | 3,412 | 3,420 | 3,250 | 3,286 | 4,017 | 4,400 | 4,805 | 5,143 |
2,573 | 2,498 | 2,162 | 2,035 | 1,989 | 1,869 | 1,762 | 1,822 | 1,925 | |
CWIP | 80 | 36 | 44 | 53 | 17 | 68 | 225 | 483 | 975 |
Investments | 61 | 58 | 0 | 0 | 4 | 9 | 32 | 50 | 58 |
895 | 821 | 1,214 | 1,162 | 1,276 | 2,071 | 2,380 | 2,450 | 2,185 | |
Total Assets | 3,608 | 3,412 | 3,420 | 3,250 | 3,286 | 4,017 | 4,400 | 4,805 | 5,143 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
293 | 252 | 376 | 327 | 339 | 589 | 629 | 440 | 584 | |
-128 | -59 | -73 | 981 | -54 | 98 | -306 | -539 | -1,305 | |
-80 | -261 | -216 | -1,193 | -201 | -28 | -119 | -109 | -112 | |
Net Cash Flow | 85 | -68 | 87 | 115 | 84 | 659 | 203 | -208 | -833 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 71 | 63 | 61 | 79 | 101 | 73 | 47 | 63 | 57 |
Inventory Days | 102 | 91 | 66 | 57 | 72 | 37 | 22 | 32 | 69 |
Days Payable | 447 | 348 | 293 | 327 | 477 | 312 | 156 | 235 | 349 |
Cash Conversion Cycle | -274 | -194 | -166 | -190 | -303 | -202 | -87 | -139 | -224 |
Working Capital Days | -70 | -69 | -73 | -25 | 12 | -3 | -9 | -12 | -29 |
ROCE % | 5% | 5% | 10% | 10% | 17% | 21% | 17% | 17% |
Documents
Announcements
-
Minutes Of 89Th Annual General Meeting Of The Company Held Through Video Conference/Other Audio-Visual Means On Thursday, 14 August 2025
28 Aug - Declared Rs12/share dividend (aggregate Rs1,023,410,676); MD Abhijit Banerjee reappointed 7 Jun 2025–6 Jun 2028.
-
Clarification On Spurt In Volume
28 Aug - Linde India (28 Aug 2025) clarifies volume spike; no undisclosed price-sensitive events pending disclosure.
-
Clarification sought from Linde India Ltd
28 Aug - Exchange has sought clarification from Linde India Ltd on August 28, 2025, with reference to Movement in Volume.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 14 Aug
- Shareholder Meeting / Postal Ballot-Outcome of AGM 14 Aug
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from nse
Concalls
-
Aug 2025TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Sep 2020TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
-
Dec 2014TranscriptNotesPPT
-
Jul 2014TranscriptNotesPPT
-
Dec 2013TranscriptNotesPPT
-
Jul 2013TranscriptNotesPPT
Business Segment
Gas and Related Products: It comprises of pipeline gas supplies to large industrial customers like primary steel, glass and chemical industries, supply of liquefied gases through Cryogenic tankers (Bulk) to cater to demand across a wide range of industrial sectors and compressed gas supply in cylinders (Packaged Gas) for meeting smaller demand for gases mainly across fabrication, manufacturing and construction industry.
Healthcare business: It provides high quality gases for pharmaceutical use such as medical oxygen, synthetic air and nitrous oxide in addition to providing state of the art medical gas distribution systems to major hospitals.
Project Engineering division (PED): It comprises the business of design, engineering, supply, installation, testing and commissioning of Air Separation plants and related projects on turnkey basis. [1][2]